We have identified you may not be viewing TRAVAX optimally because the browser you are using is unsupported - click here.

Suitcase

Enterovirus D68 Infection in United States (Update)

24 September 2014

The outbreak of enterovirus D68 infection in the United States is ongoing. As of 23 September 2014, a total of 213 cases  of EV-D68 have been laboratory confirmed. There are now 30 states reporting laboratory confirmed cases. The full list of states can be viewed at CDC.

At present there is no vaccine available and no specific treatment for EV-D68; clinical care is supportive. Symptoms may include fever, runny nose, sneezing, cough, and body and muscle aches. Those with pre-existing conditions, such as asthma or other respiratory conditions, may be particularly susceptible to severe infections from EV-D68.

(Via Centers for Disease Prevention and Control - Enterovirus D68 - accessed 24/09/14)

Advice for Travallers

As EV-D68 causes respiratory illness, the virus can be transmitted via respiratory secretions e.g. saliva, nasal mucus or sputum from an infected individual. Infection is spread person to person when an infected individual coughs, sneezes, or touches and contaminates surfaces.

Travellers should reduce the risk of respiratory illness by practicing good hand hygiene:

  • Wash hands often with soap and water, especially after changing nappies.
  • Avoid touching eyes, nose and mouth with unwashed hands.
  • Avoid kissing, hugging, and sharing cups or eating utensils with people who are unwell.
  • Disinfect frequently touched surfaces, such as toys and door handles, especially if someone is unwell.